David Rosmarin, MD
Enriched profileChair, Department of Dermatology; Associate Professor of Dermatology; Kampen-Norins Scholar in Dermatology · Indiana University School of Medicine
David Rosmarin is Chair, Department of Dermatology; Associate Professor of Dermatology; Kampen-Norins Scholar in Dermatology at Indiana University School of Medicine. OpenAlex indexes 229 publications with 5,236 citations (h-index 36); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David Rosmarin, MD, is Chair, Department of Dermatology at Indiana University School of Medicine. The public record shows 229 publications with 5,236 citations (h-index 36), centered on Dermatology and Skin Diseases, melanin and skin pigmentation, Psoriasis: Treatment and Pathogenesis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 20 companies.
- Most recent indexed publication: 2025 · Therapeutic advances in chronic disease
- Top research focus: Dermatology and Skin Diseases
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 20 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 78.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma
Sponsor: Indiana University
- Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab
Sponsor: Tufts Medical Center
- Topical Crisaborole in Patients with Alopecia Areata
Sponsor: Tufts Medical Center
Industry payments
Updated 27 Aug 2026
20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202521 payments$25,616openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20257 payments$18,759openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20259 payments$16,999openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Interleukin-4 Receptor alpha Antagonist100%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Treatment of vitiligo with ruxolitinib cream in the TRuE-V1 and TRuE-V2 studies: a plain language summary of publication.
Therapeutic advances in chronic disease
Review2025 - Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream.
Journal of the European Academy of Dermatology and Venereology
Letter2025 - Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks.
Journal of the European Academy of Dermatology and Venereology
Letter2025 - Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: A randomised controlled trial secondary analysis at 3 years.
Skin health and disease
Article2024
Most-cited works
by citation count (OpenAlex)- 02Toxic epidermal necrolysis379 citations2007
- 03
- 04
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/scientific-contributions/David-Rosmarin-2099682010
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
- Board Certified
Dermatology, American Board of Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Dermatology residency
Boston University–Tufts Combined Training Program
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗ - Fellowship
Brigham and Women's Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hmpgloballearningnetwork.com ↗
Editorial & leadership roles
journal and society appointments- Member
Association of Professors of Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Member
American Academy of Dermatology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗ - Member
American Medical Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
Awards & honors
honors on the public record- Kampen-Norins Scholar in Dermatology / Titled Professor (2023)
Indiana University School of Medicine
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.iu.edu ↗
Secondary affiliations
appointments beyond the home institution- Tufts Medical Center
former Vice-Chair for Research and Education, Department of Dermatology (ORCID lists as current employer …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
Media & interviews
press, podcasts and appearances- LearnSkin Podcast
Episode 219: "Addressing Existing Knowledge Gaps in Vitiligo" (Nov 2025), guest interview on vitiligo patient concerns, clinical trials
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →learnskin.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗
- Regular contributor/author
Dermatology Times
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dermatologytimes.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Linda Dimeglio, MD
Indiana University School of Medicine
Robert Tepper, MD
Indiana University School of Medicine
Viral Shah, MD
Indiana University School of Medicine
Khadijah Breathett, MD
Indiana University School of Medicine